{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "60001231",
    "licUnit": "1",
    "validDate": "2028-04-10 00:00:00.000",
    "issueDate": "2023-04-10 00:00:00.000",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000123103",
    "prodNameC": "莎芙諾注射劑 150毫克\/毫升",
    "prodNameE": "SAPHNELO 150 mg\/ml Concentrate for Solution for Infusion",
    "indicationsName": [
        "與標準治療併用，適用於在標準治療下仍為中度至重度的自體免疫抗體陽性之全身性紅斑性狼瘡成年病人。\r\n使用限制：目前尚未有臨床試驗顯示本品用於嚴重狼瘡腎炎或嚴重中樞神經系統狼瘡之療效與安全性。"
    ],
    "does": "227D",
    "packageUnit": [
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        },
        {
            "packageSpec": "2毫升",
            "packageUnit": "L2"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": "C",
    "mainCategory": "C",
    "drBaseId": "D2FC53A3-A1A6-463C-83E1-C11B04008D5E",
    "subCategory": [
        "C0501"
    ],
    "ingredientsDesc": [
        "Anifrolumab"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "1D",
        "5F"
    ],
    "applicantName": "臺灣阿斯特捷利康股份有限公司",
    "applicantAddr": "台北市大安區敦化南路二段207號21樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2028-04-10",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "AstraZeneca Nijmegen B.V. ",
            "factoryAddr": "Lagelandseweg 78, NIJMEGEN, 6545CG, Netherlands",
            "factoryCompanyAddr": "",
            "countryCode": "NL",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FNL0140000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "factoryCode": "2",
            "factoryName": "ASTRAZENECA AB",
            "factoryAddr": "SE-151 85 SODERTALJE SWEDEN",
            "factoryCompanyAddr": null,
            "countryCode": "SE",
            "processCode": [
                {
                    "value": "1A",
                    "name": "二級包裝廠"
                }
            ],
            "processCodeStr": "1A;二級包裝廠",
            "factoryKind": "M",
            "factoryNo": "FSE0032000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "factoryCode": "2",
            "factoryName": "ASTRAZENECA PHARMACEUTICALS LP",
            "factoryAddr": "FREDERICK MANUFACTURING CENTER, 633 RESEARCH COURT, MD 21703, FREDERICK, US",
            "factoryCompanyAddr": "",
            "countryCode": "US",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FUS0980100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013010900",
            "ingredientsName": "Anifrolumab",
            "ingredientsDesc": "Anifrolumab",
            "concentDesc": "",
            "concent": "300.0000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L04AG11"
        }
    ],
    "licBaseId": "BEB9F463-4ABB-4509-A78F-F04A33E62898"
}